Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on BIOS, GLUU, MLNX and MRK Issued by the Bedford Report

MRK
Free Research Reports on BIOS, GLUU, MLNX and MRK Issued by the Bedford Report
http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=996068&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwire) -- 03/13/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

BioScrip Inc. (NASDAQ: BIOS) shares gained 12.57 percent on over seven times the average daily volume Thursday to close at $12.27 a share. The company reported revenues of $180.7 million for the fourth quarter of 2012, compared to 158.3 million a year ago, an increase of 14.2 percent.

Find out more about BioScrip including full access to the free equity report at: www.BedfordReport.com/BIOS

Glu Mobile Inc. (NASDAQ: GLUU) shares surged 16.94 percent on volume of nearly 30 million shares traded Tuesday to close at $2.83 a share. The company announced it has launched its first real-money mobile gambling offering through Probability plc in the United Kingdom.

Find out more about Glu Mobile including full access to the free equity report at: www.BedfordReport.com/GLUU

Mellanox Technologies, Ltd. (NASDAQ: MLNX) shares rose 13.82 percent on more than three times the average daily volume Tuesday to close at $65.55 a share. Lazard Capital Markets has increased its price target on the company to $69.00. Additionally, analysts at JMP Securities have recently upgraded Mellanox's rating to "outperform" from "market perform".

Find out more about Mellanox including full access to the free equity report at: www.BedfordReport.com/MLNX

Merck & Co., Inc. (NYSE: MRK) shares spiked 3.16 percent on volume over three times the average daily volume Tuesday to close at $45.04 a share. The company announced that a Data Safety Monitoring Board has completed its review and has recommended the IMPROVE-IT trial continue.

Find out more about Merck including full access to the free equity report at: www.BedfordReport.com/MRK

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact